| Nr. | Numelestudiului | Status | Locatia/Locatiilestudiului |
| 1 | Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer | Activ, inca nu se recruteaza | Oncomed SRL, Timisoara, JUD. Timis, Romania, 300239Institutul Oncologic „Prof.Dr.I.Chiricuta” Cluj-Napoca, Cluj-Napoca, Romania, 400015 |
| 2 | An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer | In curs de recrutare | Bucharest, RomaniaCluj-Napoca, RomaniaCraiova, RomaniaIasi, Romania |
| 3 | A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101) | Activ, inca nu se recruteaza | „Prof. Dr. Ion Chiricuta” Oncology Institute, Cluj-Napoca, Romania, 400015S.C. Medisprof S.R.L., Cluj-Napoca, Romania, 400641″Sfantul Nectarie” Oncology Center, Craiova, Romania, 200347Oncomed SRL, Timisoara, Romania, 300239 |
| 4 | Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Patients With Untreated Inoperable or Metastatic Urothelial Cancer (CheckMate901) | In curs de recrutare | Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0191 Local Institution, Craiova, Romania, 200347, Contact: Site 0187 |
| 5 | A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract | Activ, inca nu se recruteaza | Oncopremium Team Srl, Baia Mare, Romania, 430291Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca; Spital de zi-Parter, Cluj-Napoca, Romania, 400015Centrul de Oncologie Sfantul Nectarie, Craiova, Romania, 200347Centrul de Radioterapie AMETHYST, Floresti, Romania, 407280Oncomed SRL; Oncologie, Timisoara, Romania, 300239 |
| 6 | An Investigational Immuno-therapy Study of Nivolumab, Compared to Placebo, in Patients With Bladder or Upper Urinary Tract Cancer, Following Surgery to Remove the Cancer (CheckMate 274) | Activ, inca nu se recruteaza | Local Institution, Bucuresti, Romania, 021389Local Institution, Craiova, Romania, 200347Local Institution, Floresti, Romania, 407280Local Institution, Timisoara, Timis, Romania, 300239 |
| 7 | A Study of Chemo Only Versus Chemo Plus Nivo With or Without BMS-986205, Followed by Post- Surgery Therapy With Nivo or Nivo and BMS-986205 in Patients With MIBC | In curs de recrutare | Institute Of Oncology „Prof.Dr.Alexandru Trestioreanu” Bucharest, Bucharest, Romania, 020122, Contact: Aurelia Alexandru, Site 0058 Local Institution, Craiova, Romania, 200347, Contact: Site 0076 |
| 8 | A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice (IMreal) | In curs de recrutare | County Hospital Alba; Oncology, Alba Iulia, Romania, 510073Centrul Medical Focus; Oncologie medicala, Bucharest, Romania, 021389University Clinical Emergency Hospital Bucharest, Bucharest, RomaniaInstitutul Oncologic Prof. Dr. Al. Trestioreanu Bucuresti, Bucuresti, Romania, 022328Sanador Medical Center; Medical Oncology, Bucuresti, RomaniaSpitalul Clinic Judetean de Urgenta Sf. Apostol Andrei Constanta, Constanta, Romania, 900591Institutul Regional de Oncologie Iasi, Iasi, Romania, 700483Spitalul Municipal Ploiesti, Ploiesti, Romania, 100337Oncomed SRL; Oncologie, Timisoara, Romania, 300239Oncocenter Timisoara , Timişoara, Romania, 300166 |
| 9 | A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial Cancer (RANGE) | Activ, inca nu se recruteaza | For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon – Fri from 9 AM to 5 PM Eastern Time (UTC/GMT – 5 hours, EST), or speak with your personal physician. Baia Mare, Romania, 430110Cluj-Napoca, Romania, 400058Craiova, Romania, 200347 |
| 10 | A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney (CheckMate 914) | In curs de recrutare | Local Institution, Bucharest, Romania, 50659, Contact: Site 0201 Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0200 Local Institution, Craiova, Romania, 200347, Contact: Site 0199 Local Institution, Lasi, Romania, 700483, Contact: Site 0202 |
| 11 | An Immunotherapy Study of Nivolumab Plus Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer | Activ, inca nu se recruteaza | Local Institution, Bucharest, Romania, 014142, Contact: Site 0076 Local Institution, Bucharest, Romania, 020122, Contact: Site 0061 Local Institution, Cluj-Napoca, Romania, 400015, Contact: Site 0056 Local Institution, Constanta, Romania, 900591, Contact: Site 0059 Local Institution, Craiova, Romania, 200347, Contact: Site 0065 |
| 12 | Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma (IMvigor130) | Activ, inca nu se recruteaza | Spitalul Judetean de Urgenta Dr Constantin Opris, Baia Mare, Romania, 430031Institute Of Oncology Bucharest; Medical Oncology, Bucharest, Romania, 022338Oncology Center Sf. Nectarie, Craiova, Romania, 200347 |
| 13 | Trial to Assess Safety and Efficacy of Lenvatinib in Combination With Everolimus in Participants With Renal Cell Carcinoma | Activ, inca nu se recruteaza | Medisprof SRL, Cluj-Napoca, RomaniaProf Dr I Chiricuta Institute of Oncology, Cluj-Napoca, RomaniaOncology Center Sfantul Nectarie, Craiova, RomaniaOncocenter Clinical Oncology, Timisoara, Romania |
| 14 | A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (CheckMate 9ER) | Activ, inca nu se recruteaza | Instit. Prof.Dr.Ion Chiricuta, Cluj-Napoca, Romania, 400015Sf. Nectarie Oncology Center, Craiova, Romania, 200347 |
| 15 | A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203) | In curs de recrutare | Centrul de Oncologie Sfantul Nectarie, Craiova, Dolj, Romania, 200347Oncolab SRL, Craiova, Dolj, Romania, 200385Medisprof SRL , Cluj-Napoca, Romania, 400461Clinical Emergency Hospital of Constanta, Constanta, Romania, 900591Center of Oncology Euroclinic, Iasi, Romania, 700106Spitalul Clinic Judetean de Urgenta Sibiu, Sibiu, Romania, 550245Oncocenter – Oncologie Clinica SRL, Timisoara, Romania, 300166 |
| 16 | Pemigatinib + Pembrolizumab vs Pemigatinib Alone vs Standard of Care for Urothelial Carcinoma (FIGHT-205) | In curs de recrutare | Spitalul Clinic Judetean de Urgenta ‘Sf Apostol Andrei’ Constanta Not yet recruiting Constanta, Romania, 900591 |
| 17 | A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer | Activ, nu se recruteaza | Local Institution Bucharest, Romania, 020122 Local Institution Cluj-Napoca, Romania, 400015 Local Institution Constanta, Romania, 900591 Local Institution Craiova, Romania, 200347 |
| 18 | Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025) | Activ, nu se recruteaza | Local Institution Bucharest, Romania, 022328 Local Institution Craiova, Romania, 200385 Local Institution Iasi, Romania, 700106 Local Institution Timisoara, Romania, 300167 |
| 19 | A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin (BCG) Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (CheckMate 7G8) | In curs de recrutare | Local Institution Not yet recruiting Bucharest, Romania, 022328 Contact: Site 0039 Local Institution Not yet recruiting Cluj-Napoca, Romania, 400015 Contact: Site 0014 Local Institution Not yet recruiting Craiova, Romania, 200347 Contact: Site 0013 |
| 20 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) Versus CRT Alone in Muscle-invasive Bladder Cancer (MIBC) (MK-3475-992/KEYNOTE-992) | In curs de recrutare | S.C. Radiotherapy Center Cluj S.R.L ( Site 0252) Recruiting Cluj-Napoca, Cluj, Romania, 407280 Contact: Study Coordinator +40742206212 S.C. Centrul de Oncologie Sf. Nectarie SRL ( Site 0248) Recruiting Craiova, Dolj, Romania, 200347 Contact: Study Coordinator +40722161545 |
(Visited 44 times, 1 visits today)